Carlos Garcia-Parada
Equibles does not estimate personal net worth.
Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCKT alertsAbout Carlos Garcia-Parada
Carlos Garcia-Parada is recorded as CFO at Rocket Pharmaceuticals, Inc. (RCKT) since January 4, 2021. The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $5,693,840 for Carlos Garcia-Parada in fiscal 2021, including a base salary of $410,000. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), John Militello (CFO) and 7 others.
Affiliation history
-
Current
2021-01-04–present
-
Start not stated–2022-03-16
Company network
Leadership on record at Rocket Pharmaceuticals, Inc.
- Gaurav Shah CEO, Board Member
- Aaron Ondrey CFO
- John Militello CFO
- Chris Stevens COO
- Christopher Stevens COO
- Martin Wilson General Counsel
- Joseph Manhede Chief Accounting Officer
- Carsten Boess Board Member
- David P. Southwell Board Member
- Dr. Mikael Dolsten, M.D., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Rocket Pharmaceuticals, Inc. (RCKT) | Former Chief Financial Officer and Principal Financial Officer | $410,000 | $5,693,840 |
Recent activity
No call appearances or filed executive changes recorded yet.